the AG formulation of long-acting MPH was in the expected direction but did not reach statistical significance versus a null hypothesis of no difference, and there is concern about potential residual bias.
← all excerpts
Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.
1
—
—